Paper10850488
Regulatory T cells: key controllers of immunologic self-tolerance.
Sakaguchi S. Cell, 2000. Cited by 1,283 papers, by iCite.
Cite this record
ConductScience Library. Regulatory T cells: key controllers of immunologic self-tolerance. Papers, record 10850488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10850488
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Self Tolerance | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| CD4-Positive T-Lymphocytes | |
| Cytokines | |
| Forecasting | |
| Humans | |
| Thymus Gland |
Source PubMed
Cited by554
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,283 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42939708 | Effectiveness of Native and Enhanced Extracellular Vesicle Preparations Assessed in Animal Models of Multiple Sclerosis: A Meta-Analysis. | Biomolecules | 2026 | https://conductscience.org/library/papers/42939708 | PubMed |
| 42787555 | NLRP3-mediated pyroptosis in cardiovascular disease: from molecular mechanisms to therapeutic targets. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42787555 | PubMed |
| 42755835 | Thirty years in, regulatory T cells are ready for medicine. | Front Immunol | 2026 | https://conductscience.org/library/papers/42755835 | PubMed |
| 42619433 | Impact of Chronic Infection-Induced Inflammation on TREG Cell Homeostasis. | Eur J Immunol | 2026 | https://conductscience.org/library/papers/42619433 | PubMed |
| 42603165 | Regulatory T cells: From Foxp3 to tolerance-inducing therapies. | J Invest Dermatol | 2026 | https://conductscience.org/library/papers/42603165 | PubMed |
| 42511524 | Immune Cytolytic Activity Correlates with Tumor Microenvironmental Aberrations in Colorectal Cancer. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511524 | PubMed |
| 42466984 | Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity. | Cancer Res | 2026 | https://conductscience.org/library/papers/42466984 | PubMed |
| 42309733 | Seminal fluid effects on female reproductive function in laboratory, livestock, and domestic species. | J Reprod Dev | 2026 | https://conductscience.org/library/papers/42309733 | PubMed |
| 42280844 | CD4+ T Lymphocytes-From Their Multiple Immunological Roles to New Sensing Strategies Using Marine Magnetotactic Bacteria-A Systematic Review. | Sensors (Basel) | 2026 | https://conductscience.org/library/papers/42280844 | PubMed |
| 42079184 | Defects in CD8+ T cell suppression by Foxp3-ΔE2 expressing regulatory T cells. | bioRxiv | 2026 | https://conductscience.org/library/papers/42079184 | PubMed |
| 42021888 | [Research Progress of Peripheral Immune Tolerance in Oral Diseases]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2026 | https://conductscience.org/library/papers/42021888 | PubMed |
| 41737211 | OX40 signaling in cancer immunotherapy: mechanisms of action, translational applications, and therapeutic perspectives. | Front Immunol | 2026 | https://conductscience.org/library/papers/41737211 | PubMed |
| 41731059 | Targeting immunometabolism for the treatment of diabetic cardiomyopathy. | Nat Cardiovasc Res | 2026 | https://conductscience.org/library/papers/41731059 | PubMed |
| 41536671 | [Targeting Regulatory T Cells to Remodel Peripheral Immune Tolerance: Research Advances and Future Directions]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2025 | https://conductscience.org/library/papers/41536671 | PubMed |
| 41424385 | IKAROS regulates human T cell phenotype at a thymic and postthymic level. | JCI Insight | 2025 | https://conductscience.org/library/papers/41424385 | PubMed |
| 41368312 | Nonclinical regulatory considerations for investigational new drug applications for regulatory T cell therapies. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41368312 | PubMed |
| 41328153 | Molecular Therapy Advances: Building the bridge between discovery and cure. | Mol Ther Methods Clin Dev | 2025 | https://conductscience.org/library/papers/41328153 | PubMed |
| 41136446 | The impact of PANoptosis-related genes on immune profiles and subtype classification in ischemic stroke. | Sci Rep | 2025 | https://conductscience.org/library/papers/41136446 | PubMed |
| 41032161 | The Targets of Immune Adverse Events in Cancer Immunotherapy by Combined Check-point Inhibitors Resemble those Seen in IPEX Patients. | J Clin Immunol | 2025 | https://conductscience.org/library/papers/41032161 | PubMed |
| 40961368 | Spices to Combat Sepsis: Curcumin and Piperine Combination Increases Survival and Modulates Immune Response in a Murine Two-Hit Trauma Model. | Shock | 2026 | https://conductscience.org/library/papers/40961368 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10850488
GET https://conductscience.org/api/papers/v1/10850488/cited_by?page=2